Key Market Segments
By Product Type
-
Standalone 3D Tomosynthesis Systems
-
2D/3D Combination Tomosynthesis Systems
-
Software Solutions
-
Full-Field Digital Mammography (FFDM) Systems
By Technology
-
3D Mammography
-
Digital Mammography
-
Contrast-Enhanced Mammography
By Application
-
Breast Cancer Screening
-
Breast Cancer Diagnosis
-
Dense Breast Imaging
By End User
-
Hospitals
-
Diagnostic Imaging Centers
-
Research Institutions
-
Others (Ambulatory Surgical Centers (ASCs), Specialty Clinics, and Mobile Imaging Units)
Request for Segment Customization as per your Business Requirement: Segment Customization Request
Regional Coverage:
North America
-
US
-
Canada
Europe
-
Germany
-
France
-
UK
-
Italy
-
Spain
-
Russia
-
Poland
-
Rest of Europe
Asia Pacific
-
China
-
India
-
Japan
-
South Korea
-
Australia
-
Rest of Asia Pacific
Middle East & Africa
-
UAE
-
Saudi Arabia
-
Qatar
-
Egypt
-
South Africa
-
Rest of Middle East & Africa
Latin America
-
Brazil
-
Argentina
-
Mexico
-
Colombia
-
Rest of Latin America
Request for Country Level Research Report: Country Level Customization Request
Available Customization
With the given market data, SNS Insider offers customization as per the company’s specific needs. The following customization options are available for the report:
-
Detailed Volume Analysis
-
Criss-Cross segment analysis (e.g., Product X Application)
-
Competitive Product Benchmarking
-
Geographic Analysis
-
Additional countries in any of the regions
-
Customized Data Representation
-
Detailed analysis and profiling of additional market players
Frequently Asked Questions
Ans: Key trends include the integration of AI in breast imaging, adoption of cloud-based radiology platforms, increased preference for 3D mammography, and digitization of imaging workflows.
Ans: North America leads the market, particularly the United States, due to high screening rates, technological advancement, and insurance coverage. Europe is the second-largest market, while Asia-Pacific is the fastest-growing region.
Ans: Top companies in the DBT market include Hologic, GE Healthcare, Siemens Healthineers, FUJIFILM Corporation, Canon Medical Systems, Philips Healthcare, and IMS Giotto S.p.A., among others.
Ans: Key drivers include the rising incidence of breast cancer, growing awareness of early diagnosis tools, increasing adoption of advanced imaging modalities, and favorable reimbursement policies in developed countries.
Ans: As of 2024, the global Digital Breast Tomosynthesis market is valued at USD 3.02 billion, driven by rising demand for early breast cancer detection and improved imaging technologies.
Get in touch
